| Typicality: | 0.480 |
| Saliency: | 0.236 |
| ideally | 6 | degree |
| through sexual contact | 6 | manner |
| to the disease | 2 | other |
| vaccine → be given before → exposure | 8 |
| vaccine → be administered before → potential exposure | 6 |
| vaccine → be administered before → infection | 3 |
| negative | neutral | positive |
| 0.225 | 0.632 | 0.143 |
| Raw frequency | 17 |
| Normalized frequency | 0.236 |
| Modifier score | 0.900 |
| Perplexity | 53.800 |